CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate
  • 2021 William B. Coley Award Recipients Drs. Katalin Karikó and Drew Weissman Receive the 2023 Nobel Prize in Physiology or Medicine 

    On October 2 the Nobel Assembly at Karolinska Institute in Stockholm, Sweden, announced that the 2023 Nobel…
    October 2, 2023| Max Mallet
  • CRI Received a 100% ‘Four-Star Charity’ Rating – Here’s Why That Matters 

    When people seek out nonprofits with missions that align with their values, it can be initially challenging…
    September 18, 2023| Max Mallet
  • How CRI-Funded Scientists are Reducing and Guarding Against Childhood Cancers 

    A cancer diagnosis is always extremely difficult news for a patient and their family. It can be…
    September 15, 2023| Max Mallet
  • Drs. Carl June and Michel Sadelain to Receive 2024 Breakthrough Prize in Life Sciences

    CRI Scientific Advisory Council member Carl June, MD (University of Pennsylvania) and CRI Clinical Accelerator Advisor Michel…
    September 14, 2023| Max Mallet
  • Cancer Cabinet Declares Updates to President Biden’s Cancer Moonshot Initiative 

    U.S. President Joe Biden’s administration is following through on last year’s commitment to reignite the White House…
    September 13, 2023| Max Mallet
  • Recent Innovations and Challenges in Fighting Blood Cancers

    The term “blood cancer” encompasses several types of cancer, including leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes (MDS),…
    August 21, 2023| Max Mallet
  • Sarcomas: Unique Cancers that Merit Further Attention and Research

    Sarcomas are unique compared to other types of cancer variations. In contrast to carcinomas, which arise from…
    July 20, 2023| Max Mallet
  • Why Do We Get Cancer? How Our Lifestyles Impact Our Risk

    There are many factors that dictate whether someone will develop cancer, and they fall roughly into two…
    July 6, 2023| Max Mallet
  • Overlaying silhouettes of women's profiles.

    Rising Female Talents in Cancer Immunotherapy Research

    In recent years, there has been a renewed and welcomed focus on female scientists in STEM (science,…
    June 5, 2023| Max Mallet

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute